Dimerix has three ‘shots on goal’ next year

Special Report: Melbourne biotech company Dimerix (ASX:DXB) expects to receive readouts on three phase 3 studies in the near term … Read More

The post Dimerix has three ‘shots on goal’ next year appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *